Invention Grant
US09550773B2 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
有权
取代的咪唑并喹啉,咪唑并吡啶和咪唑并吡啶
- Patent Title: Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
- Patent Title (中): 取代的咪唑并喹啉,咪唑并吡啶和咪唑并吡啶
-
Application No.: US14684871Application Date: 2015-04-13
-
Publication No.: US09550773B2Publication Date: 2017-01-24
- Inventor: Doris Stoermer , Joseph F. Dellaria, Jr. , David T. Amos , Bernhard M. Zimmermann , Luke T. Dressel , Jason D. Bonk , Matthew R. Radmer
- Applicant: 3M INNOVATIVE PROPERTIES COMPANY
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/14 ; A61K31/341 ; A61K31/351 ; A61K31/437 ; A61K31/445

Abstract:
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Public/Granted literature
- US20150218162A1 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES Public/Granted day:2015-08-06
Information query